More than a quarter of Scottish families are concerned about substance use

More than a quarter of residents living in Scotland are concerned about a loved one’s drug and alcohol use during the pandemic, a new survey has uncovered 

Drug and alcohol use has impacted the lives of millions of people living in the UK. In England and Wales, it’s estimated that 3.2 million people had taken drugs in the last year alone. 

The new Drug and Alcohol Survey from Delamere, has uncovered the regions and cities that are most concerned about a loved one’s drug or alcohol use. 

According to the survey data, Scotland was the location with the sixth-highest concern for drug and substance abuse. 26% of the region reported being concerned about a friend or family member’s drinking or drug use during the pandemic – that’s more than 1 in 4 people! 

The biggest worry was alcohol, with one in seven Brits saying that in the last year they have been concerned with a loved one’s drinking. Men are almost three times (32%) more likely to be worried about how drinking or substance abuse is affecting their lives, compared to women where 24% reported feeling concerned.

  • Over a third of people in the UK (36%) consumed drugs over the last 12 months 
  • 22% of adults in Britain increased their alcohol consumption during the pandemic 
  • Prescription drug misuse is on the rise, with 1 in 10 overusing prescribed medication
  • Cannabis is the most commonly used drug in the UK, with a 7% usage in the last year 
  • Brighton was the drug hotspot of the UK, with the highest rate for three drugs 

England and Wales have seen a record number of drug-related deaths during the pandemic in 2020, a total number of 4,561 deaths related to drug poisoning were registered. The new Drug and Alcohol Survey from Delamere, the private rehab clinic, has uncovered the prevalence of drug and alcohol misuse in the UK in a post-pandemic world. 

The addiction experts surveyed 2,000 adults living in the UK on their alcohol and drug consumption over the last 12 months to determine the impact of the pandemic on usage. 

Despite pubs, bars being closed for around 31 weeks in 2020, the pandemic brought an increase to the nation’s drinking habits. The survey found that one in four (22%) of adults had increased their alcohol consumption in the last year. 

Despite the nation living under lockdown restrictions, the findings uncovered that 49% of UK residents had consumed alcohol in the last twelve months alone and 36% had taken drugs. 

It’s no secret that the coronavirus pandemic and resulting shutdown of social interaction last year caused upheaval in the mental wellbeing of people across the UK. Cannabis has become a feature in many people’s lives during the lockdown, with 7% of the country using it in the last year, making it the most commonly used drug in the UK. 

Although most people take prescription medications responsibly, misuse is becoming a health concern for specialists in the United Kingdom. The survey discovered that one in ten UK residents have overused prescription medication outside of prescriptions. 

A fifth of UK respondents had purchased prescription drugs rather than obtaining them via a GP, with 7% saying they had ordered the medication through the dark web. The biggest prescription problem was found in Wales, London, West Midlands and Edinburgh. 

Experts have warned the use of illegal drugs is rising at an alarming rate across the UK, with some of the boroughs most populated areas among the worst affected areas. Brighton was the drug use hotspot in the South, with the highest rate of use for Cocaine, Ketamine and MDMA use. One in five Brighton residents reported having used cocaine, while one in ten reported using MDMA. 

The use of painkillers such as Codeine and Tramadol outside of a prescription was more prevalent in Belfast and Cardiff had the biggest rate of people taking these drugs outside of a prescription. 

Which cities are using drugs the most? 

CityCities that use each drug the mostResidents who have used the drug 
BelfastPainkillers3 in 10
LiverpoolCannabisOver 3 in 10
LiverpoolEcstasy1 in 6
Liverpool“Legal” Highs1 in 10
CardiffPrescription Drugs1 in 6
BrightonKetamine1 in 14
BrightonMDMA1 in 10
BrightonCocaine1 in 5
SheffieldOver the Counter MedicationOver 1 in 6
SheffieldHeroin1 in 20

The use of painkillers such as Codeine and Tramadol outside of a prescription was more prevalent in Belfast and Cardiff had the biggest rate of people taking these drugs outside of a prescription. 

Green Shoots: Demand for CBD soars during lockdown

Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) have launched their report Green Shoots – Sowing The Seeds Of The New UK Cannabis Industry with a new assessment of the size of the UK consumer cannabidiol (CBD) market.

The sector is now estimated to generate £690 million in annual sales for 2021. This figure surpasses predictions made in the seminal market sizing study undertaken by the CMC in 2019 which estimated the market would be worth £526 million in 2021.

The report concludes that the UK now has the most evolved regulatory framework in the world for CBD, and other consumer cannabis extracts, citing recent interventions by the Foods Standards Agency – to regulate products as dietary supplements, and by the Home Office – to consider what are safe and tolerable levels of THC contained in products.

However, the report calls for more government intervention and investment to ensure that the UK optimises what it describes as ‘Britain’s quiet cannabis revolution’.

The report claims that, due to domestic restrictions on hemp cultivation and processing in the UK, the bulk of the profits for this industry are going overseas. This is because UK farmers must destroy the parts of the hemp crop which lucrative CBD is extracted from.

The report argues that the market represents a key growth sector for the UK and it is time for the government to adopt a proactive strategy to seize opportunities in the cannabinoids sector.

The report makes 20 recommendations drawing on a submission recently made to a new governmental Taskforce on Innovation, Growth and Regulatory Reform, established by British Prime Minister Boris Johnson in February, to stimulate post-COVID economic growth.

The report authors call for:

  • A dedicated agency to licence and oversee the industry
  • A new centre of excellence to fund, synthesise and promulgate the best new clinical evidence to boost the UK’s nascent medicinal cannabis market
  • Urgent reform of licensing policy to steer and harness the emerging scientific evidence across the whole spectrum: from agri-science and plant genetics, to novel synthetics, new therapies and clinical trials.

Steve Moore – Co-Founder and Strategic Counsel to the CMC and ACI, said: “With new government support the accidental consumer cannabis revolution that has allowed CBD to become available on every high street in the UK could become permanent, nurturing hundreds of new businesses, thousands of jobs and billions of pounds in exports.

“It’s hard to imagine there many more industries that could benefit almost immediately from the proposals set out in our report.”

Paul Birch, Co-Founder of the CMC and ACI, added: “The size of this cannabinoid sector is now impossible to ignore. Today’s report reveals that sales of CBD products up to the year end of April 2021 are valued at £690m, almost a third higher than our last projection in 2019.

“Almost without notice and certainly by accident rather than design, the UK has improbably become the world’s second largest consumer cannabinoids market.”